10.2 Personnel Shielding, Dosimetry & Radiation Safety Regulations
Key Takeaways
Shield against patient scatter. Reassess barrier effectiveness when the projection or staff position changes.
Assigned collar and under-apron badges sample different exposure conditions. Their readings support estimates rather than measuring internal organ doses directly.
NRC annual TEDE, lens and skin/extremity limits are distinct. Follow the authority that regulates the clinical X-ray workplace.
NRC declared-pregnancy limits distinguish the 5 mSv gestational dose equivalent and the specified late-declaration provision from the general monthly exposure guidance.
Act on the facility follow-up trigger. A cumulative reference-air-kerma value cannot establish a specific skin finding.
10.2 Personnel Shielding, Dosimetry & Radiation Safety Regulations
Clinical Core: The irradiated patient is the principal source of scatter to staff. Use geometry, distance and shielding to reduce exposure. Interpret a staff badge, a patient dose index and an absorbed skin dose according to what each quantity represents.
Scatter and shielding
Compton scatter can redirect X-ray photons after interaction with electrons in tissue. The spatial distribution depends on the projection, beam, patient and barriers. In lateral or steep oblique projections, staff on the X-ray tube side can receive more scatter than on the receptor side. Reposition where the task allows, and recheck shielding when C-arm angulation changes. For an under-table tube, table-side drapes help intercept scatter below the tabletop. A ceiling shield placed between the irradiated region and the operator helps protect the head and upper body. Keep shields close to the source of scatter while allowing safe patient access and equipment movement. Personnel who can stand farther away can use fixed or mobile barriers as appropriate.
Select the apron or vest and skirt, thyroid protection and eyewear for the assigned task, state requirements and local radiation safety policy. Lead equivalence describes attenuation under specified measurement conditions. It does not guarantee a fixed percentage in every exam. Coverage, garment fit, eyewear side protection and shield gaps matter. Keep hands out of the primary beam. Use manufacturer-recommended storage and documented checks. Report suspected cracks, broken fasteners or poor fit and have the protective effectiveness reviewed under the facility policy. Inspection timing and rejection criteria depend on applicable requirements and the program.
Where to wear personnel dosimeters
| Monitor in an applicable program | Common position | Interpretation |
|---|---|---|
| Outside collar badge in a two-badge program | At collar level outside the apron, on the side nearer the irradiated region according to the program. | Samples unshielded exposure at the badge location and can support an estimate for the head or lens. It cannot directly measure absorbed dose to an organ. |
| Under-apron body badge in a two-badge program | On the torso under the apron at the waist or other location assigned by the program. | Samples shielded exposure at the badge. A dosimetry service can combine suitable readings to estimate effective dose. |
| Extremity or lens monitor | At the assigned location based on the anticipated highest exposure, device instructions and safety program. | Helps assess local exposure when a body badge is unsuitable. Hand selection depends on the task and geometry. |
| Assigned pregnancy monitor | At waist or abdomen under the apron when worn, following the program's instructions. | Helps estimate occupational embryo/fetal exposure. Wear separate assigned personnel badges as directed. |
U.S. regulatory context
U.S. states generally regulate clinical use of machine-produced X-rays. FDA standards address diagnostic X-ray equipment performance. NRC 10 CFR Part 20 applies to its regulated activities and licensees. The following values are for that NRC context. For the clinical fluoroscopy workplace, check the applicable state requirements and facility program. ICRP and NCRP recommendations are technical guidance unless incorporated by the relevant authority.
| 10 CFR Part 20 provision | Dose quantity or condition | Limit |
|---|---|---|
| §20.1201 annual adult occupational limits | Total effective dose equivalent (TEDE) | 50 mSv (5 rem) |
| §20.1201 annual adult occupational limits | Lens dose equivalent | 150 mSv (15 rem) |
| §20.1201 annual adult occupational limits | Shallow-dose equivalent to the skin of the whole body or any extremity | 500 mSv (50 rem) |
| §20.1201 annual adult occupational limits | Sum of deep-dose equivalent and committed dose equivalent to an individual organ or tissue other than the lens | 500 mSv (50 rem) |
| §20.1208 occupational exposure after voluntary written declaration | Embryo/fetal dose equivalent for the entire pregnancy | 5 mSv (0.5 rem), with the specific late-declaration provision below |
| §20.1301 public limit from licensed operation | Annual TEDE, with specified exclusions | 1 mSv (0.1 rem) |
| §20.1301 public limit from external sources in an unrestricted area | Any one hour, with the stated exception for released patients | 0.02 mSv (0.002 rem) |
The NRC rule defines declaration as voluntarily notifying the licensee in writing, with the estimated date of conception. Withdrawal can also be made in writing. The licensee must try to avoid substantial variation above a uniform monthly exposure rate. There is no separate hard 0.5 mSv limit for each month in this federal provision. Under its late-declaration rule, if embryo/fetal dose already exceeded 5 mSv or is within 0.5 mSv of that total at declaration, an additional dose of at most 0.5 mSv for the rest of the pregnancy meets the provision.
Patient tissue reactions and follow-up
Stochastic effects are described by their probability, such as an increased probability of cancer with increasing radiation dose in radiation-protection models. The linear no-threshold model estimates risk for radiation protection. Risk at very low dose is uncertain. Tissue reactions can follow sufficiently high absorbed dose in a particular tissue. Likelihood, onset and severity vary with local dose, exposure pattern and patient factors.
| Approximate local absorbed skin dose examples from FDA guidance | Possible response |
|---|---|
| About 2 Gy | Early transient erythema, which can appear within hours. |
| About 3 Gy | Temporary epilation, often appearing after weeks. |
| About 6–7 Gy | Main erythema around 6 Gy and permanent epilation around 7 Gy are possible, with different onset times. |
| Higher localized skin doses | Desquamation, ulceration or necrosis can occur. Timing, sensitivity and recovery vary. |
Cumulative reference air kerma () reports output at the equipment's reference location. The commonly used isocentric geometry defines that point on the central ray 15 cm toward the tube from isocenter, and the specific system's reference must be checked. Kerma–area product tracks beam output weighted by field area. Neither gives the spatial distribution of absorbed skin dose. Peak skin dose is assessed from the most exposed region with attention to projection overlap, geometry, prior irradiation of the same area and patient factors.
Worked decision. A case ends with displayed cumulative reference air kerma of 6.2 Gy. Under a local policy using AAPM's suggested 5 Gy reference-air-kerma follow-up threshold, the reading is 1.2 Gy above that operational trigger. Document the dose data and activate the follow-up plan, including communicating possible symptoms and how to seek help. Consult medical physics when the policy calls for a skin-dose estimate or review. The display alone cannot diagnose erythema. AAPM's alternative follow-up benchmark is 3 Gy peak skin dose. A lower intraprocedural notification, often 3 Gy reference air kerma with subsequent levels per policy, serves a different purpose. After a notification, reassess available exposure controls and the clinical benefit of continuing.
Under U.S. NRC 10 CFR Part 20 for an NRC licensee, which pairing correctly states the annual adult occupational TEDE limit and the usual embryo/fetal dose equivalent limit for the entire declared pregnancy?
10 mSv annually and 15 mSv for the entire pregnancy.
100 mSv annually and 1 mSv each month with no total limit.
50 mSv annually and 50 mSv for the entire pregnancy.
50 mSv annually and 5 mSv for the entire pregnancy, with efforts to avoid substantial variation above a uniform monthly exposure rate.
A facility uses an outside collar badge and an under-apron torso badge for its two-badge fluoroscopy program. What do these positions provide?
An outside-collar estimate of unshielded exposure and an under-apron measure of shielded exposure at the assigned torso position.
A direct measurement of lens absorbed dose and of energy deposited in the gonads.
Two unshielded measurements because both badges should be worn outside.
A patient entrance dose and a staff dose from a badge taped to the image receptor.
A prolonged procedure ends with 5.6 Gy cumulative reference air kerma. Facility policy follows the suggested 5 Gy reference-air-kerma follow-up level. Which interpretation is appropriate?
The peak skin dose must equal 5.6 Gy, and follow-up can wait for a rash.
The number confirms permanent skin injury and makes a dose assessment unnecessary.
The follow-up trigger has been crossed. Document the value and follow the patient protocol. Actual peak skin dose and any injury require separate assessment.
The reading is a staff dose and can be used to check the annual occupational TEDE limit.
Sections you finish are checked off in the contents.